Revenue from operations grew 3.4% quarter-on-quarter to ₹1,328.9 crore, driven by growth in its BFSI and Lifesciences & Services verticals, even as the manufacturing segment saw some softness.
Operating performance showed improvement. EBIT jumped 37.9% QoQ to ₹193 crore, while margins expanded to 14.5% from 10.9% in the June quarter. EBITDA rose 34.3% QoQ to ₹213.3 crore, taking the margin to 16%. The company’s cash and cash equivalents stood at ₹2,343.4 crore, up 3% sequentially and 26% year-on-year.
CEO Angan Guha said the quarter reflected "healthy execution despite a challenging macro environment," while CFO Chandrasekar Thyagarajan noted that the company continues to prioritise "operational efficiency, cash flow generation, and prudent capital allocation."
During the quarter, Birlasoft signed deals worth $107 million in total contract value (TCV), including $40 million in new deals. The company also announced an interim dividend of ₹2.50 per share.
At the end of Q2FY26, the company’s headcount stood at 11,892 employees, with attrition steady at 13.3%.
The shares of the company ended close to a percent in the green on Thursday (November 6). The stock has fallen 33.6% in the year so far.
Catch live Q2 updates with CNBC-TV18.com's blog
/images/ppid_59c68470-image-176243507278360825.webp)

/images/ppid_59c68470-image-176242012173174797.webp)
/images/ppid_59c68470-image-176236254294949561.webp)
/images/ppid_59c68470-image-176238754433393423.webp)
/images/ppid_59c68470-image-176227002995432123.webp)
/images/ppid_59c68470-image-176233504322233236.webp)
/images/ppid_59c68470-image-176216006167971618.webp)
/images/ppid_59c68470-image-176224504366128059.webp)
/images/ppid_59c68470-image-1762230139610280.webp)
/images/ppid_59c68470-image-176224759165313108.webp)
/images/ppid_59c68470-image-176225257807599133.webp)